WEBINAR Detail:

EVIDENCE-BASED MANAGEMENT TO REDUCE CARDIOMETABOLIC RISK

Subscription:
Free
Date:
10/11/2020
Office:
Platform:

A major paradigm shift was introduced by the 2019 ESC guidelines on diabetes, prediabetes and CVD, recommending SGLT-2i or GLP-1 RAs with proven CV benefits in patients with atherosclerotic cardiovascular disease (ASCVD) or high/very high CV risk irrespective of HbA1c level. In the perspective of empowering clinicians to integrate evidence-based therapies into practice, our webinar will address the current management of cardiometabolic risk and provide a vision for the future.


CHAIRMAN

FRANCESCO COSENTINO

Unit of Cardiology Department of Medicine

Solna Karolinska Institute & Karolinska University Hospital Stockholm, Sweden 

Reserved area

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Pills of Art”
A new multimedia project dedicated to the art world.



Press Release:
Restyling Minuti



Minuti Menarini Online

Beside the Scientific Edition, Fondazione Menarini edits the publication of the Artistic Edition of "Minuti Menarini" addressed to all Italian doctors who love art



Fondazione Internazionale Menarini



SIGN UP FOR THE NEWSLETTER

Receive information about the Fondazione Internazionale Menarini every month.

VGFM DATA-LAYER

Fondazione Internazionale Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484